Johnson, Mr Colin

MChir, FRCS

Speciality

General surgery

Sub-speciality

Pancreatic Surgery

Training and Education

Cambridge and the London Hospital; registrar posts in London and Bristol; Senior Registrar Westminster and St Stephen’s Hospitals; MRC Travelling Fellow INSERM, Marseille

Experience

Mr Johnson has worked for Southampton University Hospitals Trust since 1988. 

Trained as a Gastrointestinal Surgeon, and specialised in pancreatic surgery. Visiting Fellow in Pancreatic Surgery, Ulm and Erlangen, Germany, 1990.
Extensive experience of operating on pancreatic tumours, and chronic pancreatitis. Expert specialist management of acute pancreatitis

Key achievements

Co-ordinated the writing of BSG Guidelines on the management of pancreatic cancer, and led the revision of UK Guidelines for the management of acute pancreatitis, both published 2005. My research on organ failure in acute pancreatitis is now incorporated into practice guidelines worldwide.

President of Pancreatic Society 2001 (Secretary 1993-1998) ; Chair of Pancreatic Section of BSG 1998-2001 (Secretary 1993-1998). Past council Member of European Pancreatic Club, and International Association of Pancreatology.
Led the bid for and the development programme for centralisation of pancreatic surgery in Central South Coast and Dorset Cancer Networks 2004-2007.
Associate/Review Editor of British Journal of Surgery 1991-1999, Annals of Royal College of Surgeons Review Editor 2005-2009, Editor in Chief 2009

Key awards and prizes

Arris and Gale Lecture of Royal College of Surgeons 2001
Pancreatic Society Poster Prize (co-author) 1996, 1997, 2008

Research

(selected from over 100 peer reviewed publications)

National statistics for diet, alcohol consumption and chronic pancreatitis in England and Wales 1960-1988. Johnson CD, Hosking S. Gut 1991; 32: 1401-1405
Standardisation of a technique for BRIDA Cholescintigraphy. Patankar  R, Ozmen MM, Aldous A, Khader Z, Fleming JS, Johnson CD. Nuclear Medicine Communications 1996; 17: 724-8

Development of a disease-specific Quality of Life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire the QLQ-C30 in patients with pancreatic cancer. Fitzsimmons D, Johnson CD, George S, Payne S, Andren-Sandberg A, Bassi C et al, on behalf of the EORTC Quality of Life Study Group. Eur J Cancer 1999 35: 939-941

Double blind, randomised, placebo-controlled study of a platelet activation factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.  Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, McKay C, Toh SK, Skaife PJ, Leeder PC, Wilson P, Larvin M, Curtis LD.  Gut 2001; 48: 62-69

Persistent organ failure during the first week as a marker of fatal outcome in
acute pancreatitis. Johnson CD and Abu-Hilal M for the British Acute Pancreatitis Study Group. Gut 2004; 53:1340-1344

Symptoms and Quality of Life in Chronic Pancreatitis Assessed by Structured Interview and the EORTC QLQ-C30 and QLQ-PAN26. Fitzsimmons D, Kahl S, Butturini G, van Wyk M, Bornman P, Bassi C, Malfertheiner P, George SL, Johnson CD.  American Journal of Gastroenterology 2005;100:918–926

Fitzsimmons D, Gilbert J, Howse F, Young T, Arrarras JI, Brédart A, Hawker S, George S, Aapro M, Johnson CD. A systematic review of the use and validation of health-related quality of life instruments in older cancer patients. Eur J Cancer. 2009; 45: 19-32.